Dr. Ravi Majeti: Transforming the Detection of Minimal Residual Disease (MRD) with Single-Cell DNA Analysis

RESEARCHER SPOTLIGHT

Dr. Ravi Majeti shares his thoughts on using the Tapestriā„¢ Platform to measure residual disease in acute myeloid leukemia (AML)